Sharma Rohit, Padwad Yogendra
Pharmacology and Toxicology Laboratory, Food & Nutraceutical Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, India.
Pharmacology and Toxicology Laboratory, Food & Nutraceutical Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, India.
Nutrition. 2020 Sep;77:110785. doi: 10.1016/j.nut.2020.110785. Epub 2020 Mar 2.
There is a growing interest in identifying alternatives to traditional oligosaccharide-based prebiotic agents owing to their undesirable attributes, such as a lack of microbial growth specificity and limited inherent bioactivity. In addition, a novel concept of second-generation synbiotic agents is currently emerging, which argues that prebiotic agents could be best defined on the basis of their physiological effects or functional capacities in the host rather than their specific microbial targets. Plant polyphenols are rapidly emerging as suitable prebiotic and synbiotic candidates that may fulfil these criteria. As we begin to understand the intricate interrelationship between dietary polyphenols and the gut microbiome, a functional synergy can be observed that suggests the appropriateness of the amalgamation of polyphenols and probiotic agents to develop second-generation synbiotic agents. In the present review, we study evidence pertaining to the prebiotic and synbiotic attributes of polyphenols, as well as their relationship with probiotic bacteria, and discuss their efficacy, suitability, and strategies to develop second-generation synbiotic agents. We provide a perspective that polyphenol-based synbiotic agents are fundamentally superior to the traditional carbohydrate-based synbiotic agents and could therefore offer health benefits of both polyphenols and probiotic agents in a synergistic manner.
由于传统的基于低聚糖的益生元制剂存在一些不良特性,如缺乏微生物生长特异性和固有的生物活性有限,因此人们越来越关注寻找其替代物。此外,第二代合生元制剂的新概念目前正在兴起,该概念认为益生元制剂最好根据其在宿主中的生理效应或功能能力来定义,而不是根据其特定的微生物靶点。植物多酚正迅速成为可能符合这些标准的合适益生元和合生元候选物。随着我们开始理解膳食多酚与肠道微生物群之间复杂的相互关系,可以观察到一种功能协同作用,这表明将多酚与益生菌制剂合并以开发第二代合生元制剂是合适的。在本综述中,我们研究了与多酚的益生元和合生元特性相关的证据,以及它们与益生菌的关系,并讨论了它们的功效、适用性以及开发第二代合生元制剂的策略。我们提出一种观点,即基于多酚的合生元制剂从根本上优于传统的基于碳水化合物的合生元制剂,因此可以以协同方式提供多酚和益生菌制剂的健康益处。